ABCL
insider transactionsAbCellera Biologics Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
+20.0K
20.0K buy · 0 sell
Net value · 90d
$95.4K
$95.4K in · $0 out
Sentiment · 90d
Net buying
100% buying · 0% selling
Open-market trades · 90d
1
20.0K buy · 0 sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
111.7K sh
Own +11%
-
Grant·A
Director
$0
111.7K sh
Own +57%
-
Grant·A
Director
$0
111.7K sh
Own +12%
-
Exercise·M
Andrew Booth KEY
Chief Financial Officer
$0
250.0K sh
Own +3%
-
Exercise·M
Andrew Booth KEY
Chief Financial Officer
$47.5K
250.0K sh · $0.19
Own +128%
-
Buy·P
Director
$95.4K
20.0K sh · $4.77
Own +9%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | John S. Montalbano | Grant A | 111.7K | $0 |
| Jun 11, 2026 | Stephen Quake | Grant A | 111.7K | $0 |
| Jun 11, 2026 | Michael R Hayden | Grant A | 111.7K | $0 |
| Jun 3, 2026 | Andrew Booth KEY | Exercise M | 250.0K | $0 |
| Jun 3, 2026 | Andrew Booth KEY | Exercise M | 250.0K | $47.5K |
| May 14, 2026 | John S. Montalbano | Buy P | 20.0K | $95.4K |
About ABCL insider trading
This page tracks insider transactions for AbCellera Biologics Inc. (ABCL) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.